CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, December 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 3,699 followers.

RT @JournalofExper1: Just published!✅ CBL0137 impairs homologous recombination repair and sensitizes high-grade serous #ovariancarcinoma t…

CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors https://t.co/EIaZNN1xz8

CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carc... https://t.co/UFWOE0X3Pj

RT @JournalofExper1: Just published!✅ CBL0137 impairs homologous recombination repair and sensitizes high-grade serous #ovariancarcinoma t…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.